References
- Marsh DG, Goodfriend L, King TP, Lowenstein H, Platts-Mills TA. Allergen nomenclature. Bull World Health Organ. 1986;64:767–74.
- Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50:1–26. doi:https://doi.org/10.1111/j.1574-695X.2007.00232.x.
- Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30:564–95. doi:https://doi.org/10.1111/j.1574-6976.2006.00023.x.
- Serrano-Luna Jde J, Cervantes-Sandoval I, Calderón J, Navarro-García F, Tsutsumi V, Shibayama M. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii. Can J Microbiol. 2006;52:16–23. doi:https://doi.org/10.1139/w05-114.
- Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16:273–307. doi:https://doi.org/10.1128/CMR.16.2.273-307.2003.
- Park MK, Cho MK, Kang SA, Park HK, Kim DH, Yu HS. Acanthamoeba protease activity promotes allergic airway inflammation via protease-activated receptor 2. PLoS One. 2014;9:e92726. doi:https://doi.org/10.1371/journal.pone.0092726.
- Park HK, Park MK, Kim KU, Kang SA, Park SK, Ahn SC, Kim DH, Yu HS. Evaluation of allergic sensitivity to Acanthamoeba allergen in patients with chronic cough. Allergy Asthma Proc. 2016;37:141–47. doi:https://doi.org/10.2500/aap.2016.37.3922.
- Solomon A, Pe’er J, Levi-Schaffer F. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol. 2001;1:477–82. doi:https://doi.org/10.1097/00130832-200110000-00015.
- Fukuda K, Ohbayashi M, Morohoshi K, Zhang L, Liu FT, Ono SJ. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. J Allergy Clin Immunol. 2009;124:827–33. doi:https://doi.org/10.1016/j.jaci.2009.06.012.
- Miyazaki D, Tominaga T, Yakura K, Kuo CH, Komatsu N, Inoue Y, Ono SJ. Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy. Mol Vis. 2008;14:1525–32.
- Hayashi D, Li D, Hayashi C, Shatos M, Hodges RR, Dartt DA. Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion. Invest Ophthalmol Vis Sci. 2012;53:2993–3003. doi:https://doi.org/10.1167/iovs.11-8748.
- Martin N, Ruddick A, Arthur GK, Wan H, Woodman L, Brightling CE, Jones DJ, Pavord ID, Bradding P. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. PLoS One. 2012;7:e43545. doi:https://doi.org/10.1371/journal.pone.0043545.
- Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol. 2011;186:4455–66. doi:https://doi.org/10.4049/jimmunol.1000833.
- Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol. 2000;105:1185–93. doi:https://doi.org/10.1067/mai.2000.106210.
- Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol. 2002;169:5904–11. doi:https://doi.org/10.4049/jimmunol.169.10.5904.
- Wong AH, Barg SS, Leung AK. Seasonal and perennial allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov. 2014;8:139–53. doi:https://doi.org/10.2174/1872213X08666140704113452.
- Wang YH, Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy. 2009;39:798–806. doi:https://doi.org/10.1111/j.1365-2222.2009.03241.x.
- Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, Kay AB. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 2002;169:2712–18. doi:https://doi.org/10.4049/jimmunol.169.5.2712.
- Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272:15036–42. doi:https://doi.org/10.1074/jbc.272.23.15036.
- Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, Omori M, Zhou B, Ziegler SF. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol. 2007;25:193–219. doi:https://doi.org/10.1146/annurev.immunol.25.022106.141718.
- Arita M. Mediator lipidomics in acute inflammation and resolution. J Biochem. 2012;152:313–19. doi:https://doi.org/10.1093/jb/mvs092.
- Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. Resolvins and omega three polyunsaturated fatty acids: clinical implications in inflammatory diseases and cancer. World J Clin Cases. 2016;4:155–64. doi:https://doi.org/10.12998/wjcc.v4.i7.155.
- Saban DR, Hodges RR, Mathew R, Reyes NJ, Yu C, Kaye R, Swift W, Botten N, Serhan CN, Dartt DA. Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model. Mucosal Immunol. 2019;12:145–53. doi:https://doi.org/10.1038/s41385-018-0089-1.
- Li D, Hodges RR, Jiao J, Carozza RB, Shatos MA, Chiang N, Serhan CN, Dartt DA. Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. Mucosal Immunol. 2013;6:1119–30. doi:https://doi.org/10.1038/mi.2013.7.